Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, United States.
Int J Cardiol. 2011 May 19;149(1):4-9. doi: 10.1016/j.ijcard.2010.09.048. Epub 2010 Oct 29.
Health related quality of life (HRQoL) is used increasingly as a measure of the outcome of CHD. As an improvement in survival of CHD continues, assessment of HRQoL has become an important and useful outcome measure complementing the traditional "hard outcomes" such as mortality for evaluating benefits of medical interventions. Increasing number of clinical trials is applying HRQoL as an outcome measure of CHD therapy. Assessment of HRQoL in CHD should comprise a disease-specific measure in addition to a generic measure. This review aims to provide an overview of generic, disease-specific, and utility measures used in the assessment of HRQoL in CHD.
健康相关生活质量(HRQoL)越来越多地被用作冠心病(CHD)结果的衡量标准。随着 CHD 生存率的提高,HRQoL 的评估已成为评估医疗干预措施益处的重要且有用的替代传统“硬结果”(如死亡率)的结果衡量标准。越来越多的临床试验将 HRQoL 作为 CHD 治疗的结果衡量标准。CHD 中 HRQoL 的评估应包括特定于疾病的衡量标准以及通用衡量标准。本综述旨在提供用于评估 CHD 中 HRQoL 的通用、特定于疾病和效用衡量标准的概述。